geoscience.net logo
+ Resolve Article
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter

+ Translate
+ Subscribe to Site Feed
GeoScience Most Shared ContentMost Shared Content

Long-term fluoxetine treatment of late luteal phase dysphoric disorder


, : Long-term fluoxetine treatment of late luteal phase dysphoric disorder. Journal of Clinical Psychiatry 55(8): 332-335

Background: The safety and efficacy of fluoxetine in the short-term treatment of late luteal phase dysphoric disorder (LLPDD) have been shown in several studies, but its efficacy and safety over more than a few cycles have not been demonstrated. Method: Sixty-four women with prospectively confirmed LLPDD were treated with fluoxetine for a mean of 18.6 months. Response was determined by clinical interview and Clinical Global Impressions rating within the first three cycles, and subjects were followed clinically every 3 to 6 months. Medication dose was titrated on the basis of side effects and response. Women who had been treated for at least 1 year were asked to discontinue medication to reassess the need for treatment. Results: Sixty women were able to tolerate at least 1 month of treatment. Of these, 57% (N = 34) remained on 20 mg/day and 37% (N = 22) received 40 mg/day. Fifty-two percent (N = 31) achieved remission (CGI score = 1); 48% (N = 29) achieved a partial remission of symptoms (CGI score = 2). The most common side effect was sexual dysfunction, which occurred in 17% of women (N = 10). Symptoms recurred in most women after treatment discontinuation and remitted again with reinstitution of treatment. An earlier age at onset of LLPDD or a prior episode of major depression was associated with achieving only partial remission of symptoms. Conclusion: These results support the findings of the double-blind studies of fluoxetine treatment for LLPDD. Fluoxetine is an effective and well-tolerated treatment for this condition when used over time. Approximately half of those treated achieved complete remission of their symptoms, while the others experienced significant improvement. This study also lends further support to the effectiveness of serotonergic agents in the treatment of premenstrual symptoms.

US$29.90

PMID: 8071300


Other references

Migliore, A.; Broccoli, S.; Massafra, U.; Cassol, M.; Frediani, B., 2013: Ranking antireabsorptive agents to prevent vertebral fractures in postmenopausal osteoporosis by mixed treatment comparison meta-analysis. Bisphosphonates are considered as a first-line therapy for the prevention and treatment of osteoporosis, showing in double-blind, randomized, controlled trials a significant reduction of incidence of new vertebral fractures compared to placebo. Re...

Noordeloos, M.E.; Woelfel, G.; Enderle, M., 1995: New Entoloma species from Southern Germany and the alps. Several new taxa of Entoloma from Southern Germany are described, viz. Entoloma dolosum in subgenus Nolanea, characterized by its large many-angled to nodulose spores; Entoloma caesiellum, a Leptonia of stirps Cyanula with relatively pale basidioc...

Walker, A.; Strom, R.L., 1966: Sulfonamide-resistant Neisseria meningitidis in Minneapolis. Minnesota Medicine 49(2): 232-236

Singh R.; Fazzaro R.D.; Ayvazian L.H., 1979: Remote childhood odd job exposures associated with adult pulmonary disease. American Review of Respiratory Disease 119(4 PART 2): 235

Ntim, Ba, 1986: Low-cost technology and the promotion of rural industrial development. Rural development in Ghana edited by CK Brown: 123

Holsen, L.; Thompson, T., 2004: Compulsive behavior and eye blink in Prader-Willi syndrome: neurochemical implications. Compulsive behavior in Prader-Willi syndrome is well-documented, though the neurochemical basis of these behaviors remains unknown. We studied a group of 16 people with Prader-Willi syndrome and a comparison group of 19 people with intellectual di...

Noda, Y.; Suzuki, T.; Kohara, A.; Hasegawa, A.; Yotsuyanagi, T.; Hayashi, M.; Sofuni, T.; Yamanaka, K.; Okada, S., 2001: In vivo genotoxicity evaluation of dimethylarsinic acid in MutaMouse. Dimethylarsinic acid (DMA) induces DNA damage in the lung by formation of various peroxyl radical species. The present study was conducted to evaluate whether arsenite or its metabolite, DMA, could initiate carcinogenesis via mutagenic DNA lesions...

Sun, N.; Sun, Z., 1992: The expression of oncogenes in the development of human brain. Seven oncogenes (c-myc, L-myc, N-myc, v-erbB, c-fos, Ha-ras and mos) were used as the probe to detect the total RNA of every part (cerebellum, temporal folium, frontal folium and occipital folium) in human brain from 2 cases of 6 mon fetus and the...

Martens, H.; Thybo, A.K.; Andersen, H.J.; Karlsson, A.H.; Donstrup, S.; Stodkilde-Jorgensen, H.; Martens, M., 2002: Sensory analysis for magnetic resonance-image analysis: Using human perception and cognition to segment and assess the interior of potatoes. The human ability to detect, interpret, assess and report visual stimuli is employed for qualitative and quantitative image analysis. Cross-sectional T1 weighted MR images were acquired from a series of intact potatoes. Descriptive sensory image a...

Imaichi, K.; Michaels, G.D.; Gunning, B.; Grasso, S.; Fukayama, G.; Kinsell, L.W., 1963: Studies With The Use Of Fish Oil Fractions In Human Subjects. Quantitatively constant ingestion of fish and of a fish liver oil fraction containing relatively large amounts of eicosapentaenoic and docosahexaenoic acids results in predictable amounts of these acids in specific plasma lipid fractions in human...